Form 4: Eastman Chemical CEO Granted Equity Awards

Eastman Chemical CEO Mark J. Costa received significant equity awards, including stock options and restricted stock units, on February 24, 2026.

Summary

• Mark J. Costa, CEO and Board Chair of Eastman Chemical Co. (EMN), was granted equity awards on February 24, 2026.
• The awards include 232,559 employee stock options with an exercise price of $77.12 per share.
• These stock options will become exercisable in three equal annual installments on February 24, 2027, February 24, 2028, and February 24, 2029, respectively, and expire on February 23, 2036.
• Additionally, 31,993 restricted stock units (RSUs) were granted.
• Each RSU represents a contingent right to receive one share of Eastman Chemical common stock.
• The restricted stock units will vest and pay out in unrestricted shares of Company common stock on February 24, 2029, subject to continued employment.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as it represents routine executive compensation designed to align management's interests with shareholders, without indicating any extraordinary operational or financial developments.

Positives

• The grant of equity awards to the CEO aligns management's long-term interests with those of shareholders, incentivizing sustained company performance.
• The structure of both stock options and restricted stock units provides a balanced incentive, linking compensation to both stock price appreciation and continued service.

Future Outlook

The future outlook involves the vesting of 232,559 employee stock options in annual installments from February 24, 2027, to February 24, 2029, and their expiration on February 23, 2036. Additionally, 31,993 restricted stock units are set to vest and pay out on February 24, 2029, contingent on continued employment.

Industry Context

StockSavvy.ai notes that the grant of equity awards to a CEO is a standard practice in the chemical industry and broader corporate landscape, designed to align executive incentives with long-term shareholder value creation.

Comparison to Industry Standards

• Equity compensation packages for CEOs in the chemical sector, such as those at DuPont or Dow, typically include a mix of stock options and restricted stock units, similar to the structure seen here for Eastman Chemical's CEO.
• The specific number of units granted would be benchmarked against company size, performance, and peer group compensation data, though this filing does not provide such comparative details.

Stakeholder Impact

• Shareholders: The equity grants are intended to align the CEO's financial interests with long-term shareholder value creation.
• Employees: The CEO's compensation structure may influence overall compensation philosophy within the company.

Next Steps

• Vesting of employee stock options in annual installments from February 24, 2027, to February 24, 2029.
• Vesting and payout of restricted stock units on February 24, 2029.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to the CEO and does not contain information that would fundamentally alter the investment thesis for Eastman Chemical. It is a standard disclosure of executive remuneration, not indicative of significant operational changes or financial performance shifts that would warrant a change in investment recommendation.

Keywords

EMN, Eastman Chemical, Mark J. Costa, CEO, Stock Options, Restricted Stock Units, Equity Compensation, Insider Transaction, Form 4